Arachidonic acid release from cellular membranes due to spinal cord trauma
may be one of the principal destructive events that can lead to progressive
injury to spinal cord tissue. Exposure to arachidonic acid can compromise
neuronal survival and viability. Because nicotine is known to be a neuropro
tective agent, we propose that it can prevent arachidonic acid-induced neur
otoxicity. To study this hypothesis, effects of nicotine on mitochondrial f
unction, cellular energy content and apoptotic cell death were measured in
cultured spinal cord neurons treated with arachidonic acid. Nicotine attenu
ated arachidonic acid-induced compromised cell viability and cellular ATP l
evels in spinal cord neurons. Nicotine exerted these protective effects whe
n used at the concentration of 10 mu M and only after a 2-h pre-treatment b
efore a co-exposure to arachidonic acid. Antagonists of nicotinic receptors
, such as alpha-bungarotoxin or mecamylamine, only partially reversed these
neuroprotective effects of nicotine. In addition, nicotine prevented arach
idonic acid-induced activation of caspase-3 activity and apoptotic cell dea
th. These results indicate that nicotine pre-treatment can exert a protecti
ve effect against arachidonic acid-induced injury to spinal cord neurons. (
C) 2000 Elsevier Science B.V. All rights reserved.